CC
BLCM

Clearline Capital’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Clearline Capital’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-5,520
Closed -$681K – 54
2017
Q1 		$681K Buy
+5,520
New +$681K 0.32% 44